Customize your JAMA Network experience by selecting one or more topics from the list below.
On behalf of our team here at JAMA Neurology, I want to thank everyone who has contributed to the journal in 2017. A scientific publication is only as strong as its editors, board, reviewers,1 authors, and readers, and we are incredibly fortunate to have so many great friends and colleagues who have taken the time to help make JAMA Neurology successful over the past 12 months.
It has been a busy year for us, with new peaks in numbers of submissions of major manuscripts (1945) and research manuscripts (1472) (Table). Because of this increase in submissions as well as our rise in impact factor to more than 10, we have needed to become more selective and had an overall acceptance rate of 12% and an acceptance rate of 9% for research articles. Despite this higher volume, the journal’s editors and reviewers have put in numerous hours to ensure we continue to have a rapid response time, with a median time from receipt to first decision of 1 day without peer review and 8 days with peer review.
Impact factor is only one measure of a journal’s success, and we have emphasized online offerings and social media outlets as important ways to reach our readers and to magnify the effect of the articles we publish. In 2017, there were a record 4.1 million downloads of content via our redesigned website (http://www.jamaneurology.com). The journal has nearly 39 000 Facebook followers and 22 000 Twitter followers. In 2017, JAMA Neurology had 14 of the top 50 articles in major neurology journals with Altmetric scores, a measure of articles’ news and social media coverage, including the 3 articles listed in the Table.2-4 Although we continue to hear from readers about the importance of a monthly print issue publication, the journal has increasingly transformed into a weekly online journal in which new content is rapidly published each Monday morning and sent to more than 38 000 recipients of our electronic table of contents.
We have continued to publish outstanding research across an increasingly broad set of neurologic subspecialties and topics. One of our most important initiatives in the past year has been working to make the journal’s articles more diverse than ever, striving to cover all aspects of neurology. Increasing emphasis on clinical trials as well as publishing the best translational research has allowed us to focus on articles that help in clinical practice while framing the future of neurology and neuroscience.
In addition, as a new editorial team wrapping up our first year, we have worked extremely hard to connect with readers and to take suggestions about how to improve our content. In addition to the popular Viewpoints section, we have added additional opportunities to address humanistic areas of neurology with our On the Brain series while continuing to boost our educational content with Clinical Challenges as well as more Continuing Medical Education offerings and podcasts.
At the end of the day, JAMA Neurology is your journal, not ours, and we would very much appreciate any suggestions you have to help us better serve your needs. Thanks to all who have been part of the team, and we can’t wait to see what 2018 will bring.
Corresponding Author: S. Andrew Josephson, MD, Department of Neurology, University of California, San Francisco, 505 Parnassus Ave, San Francisco, CA 94143 (firstname.lastname@example.org).
Published Online: March 12, 2018. doi:10.1001/jamaneurol.2017.4343
Conflict of Interest Disclosures: None reported.
Josephson SA. JAMA Neurology—The Year in Review, 2017. JAMA Neurol. 2018;75(5):540–541. doi:10.1001/jamaneurol.2017.4343
Coronavirus Resource Center